MiNK Therapeutics, Inc. - COM NEW (INKT)

CUSIP: 603693201

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / COM NEW
Total 13F shares
125,832
Share change
-26,220
Total reported value
$1,324,781
Price per share
$10.53
Number of holders
22
Value change
-$298,740
Number of buys
5
Number of sells
9

Security key

603693201

Report period

Q1 2026

Institutions

22

Top holders

10

Top shareholders of INKT - MiNK Therapeutics, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AGENUS INC
3/4/5
10%+ Owner
class O/S missing
21,772,863
$22,643,778 12 Oct 2023
Garo H. Armen
3/4/5
Director
class O/S missing
1,966,400
$2,045,056 05 May 2023
VANGUARD GROUP INC
13F
Company
class O/S missing
67,651
$754,309 31 Dec 2025
13F
Jennifer Buell
3/4/5
Chief Executive Officer
mixed-class rows
107,942
mixed-class rows
$644,315 02 Jan 2026
Ulf Wiinberg
3/4/5
Director
mixed-class rows
53,459
mixed-class rows
$605,109 02 Jan 2026
Brian Corvese
3/4/5
Director
mixed-class rows
55,448
mixed-class rows
$555,087 02 Jan 2026
Barbara Ryan
3/4/5
Director
mixed-class rows
25,801
mixed-class rows
$312,211 -$27,478 09 Mar 2026
DRW Securities, LLC
13F
Company
class O/S missing
25,677
$286,298 31 Dec 2025
13F
Peter Behner
3/4/5
Director
mixed-class rows
25,510
mixed-class rows
$223,075 02 Jan 2026
Robert Peter Kadlec
3/4/5
Director
mixed-class rows
64,096
mixed-class rows
$212,107 01 Dec 2025
Longbow Finance SA
13F
Company
class O/S missing
16,667
$185,837 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
14,247
$158,878 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
10,400
$115,960 31 Dec 2025
13F
UBS Group AG
13F
Company
class O/S missing
9,548
$106,461 31 Dec 2025
13F
BlackRock, Inc.
13F
Company
class O/S missing
6,203
$69,164 31 Dec 2025
13F
Christine M. Klaskin
3/4/5
Treasurer
class O/S missing
55,660
$57,886 13 Oct 2021
John Baldoni
3/4/5
Director
class O/S missing
41,193
$42,841 01 Sep 2023
John Bradley Holcomb
3/4/5
Director
mixed-class rows
5,302
mixed-class rows
$12,509 01 Dec 2025
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
568
$6,333 31 Dec 2025
13F
CITIGROUP INC
13F
Company
class O/S missing
337
$3,758 31 Dec 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
295
$3,289 31 Dec 2025
13F
Melissa Orilall
3/4/5
Principal Financial Officer
class O/S missing
222
$2,282 13 Mar 2026
HORIZON FINANCIAL SERVICES, LLC
13F
Company
class O/S missing
160
$1,784 31 Dec 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
117
$1,303 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
class O/S missing
104
$1,160 31 Dec 2025
13F
Covestor Ltd
13F
Company
class O/S missing
131
$1,000 31 Dec 2025
13F
Austin Charette
3/4/5
Principal Accounting Officer
class O/S missing
40
$441 13 Mar 2026
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
20
$223 31 Dec 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
class O/S missing
18
$201 31 Dec 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
class O/S missing
16
$178 31 Dec 2025
13F
Game Plan Financial Advisors, LLC
13F
Company
class O/S missing
16
$178 31 Dec 2025
13F
Clearstead Advisors, LLC
13F
Company
class O/S missing
14
$157 31 Dec 2025
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
9
$100 31 Dec 2025
13F
Pinnacle Wealth Planning Services, Inc.
13F
Company
class O/S missing
5
$56 31 Dec 2025
13F
BARCLAYS PLC
13F
Company
class O/S missing
4
$45 31 Dec 2025
13F
Key FInancial Inc
13F
Company
class O/S missing
4
$45 31 Dec 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
class O/S missing
1
$11 31 Dec 2025
13F
Marc Antonius van Dijk
3/4/5
Chief Scientific Officer
class O/S missing
171,078
16 Jan 2024

Institutional Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q1 2026

As of 31 Mar 2026, MiNK Therapeutics, Inc. - COM NEW (INKT) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 125,832 shares. The largest 10 holders included VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Longbow Finance SA, UBS Group AG, VANGUARD FIDUCIARY TRUST CO, BlackRock, Inc., Steward Partners Investment Advisory, LLC, Annis Gardner Whiting Capital Advisors, LLC, Tower Research Capital LLC (TRC), and Covestor Ltd. This page lists 22 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
23
Q1 2026 holders
22
Holder diff
-1
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .